Cargando…

Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis

BACKGROUND AND AIMS: Recently, the abnormal expression of FoxM1 has been found in many malignant tumors. However, the clinicopathological and prognostic value of FoxM1 expression in hepatocellular carcinoma (HCC) patients remains controversial. We conducted a meta-analysis to establish the relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Chaojie, Zhao, Jingyang, Ge, Hua, Li, Guangming, Wu, Jixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016270/ https://www.ncbi.nlm.nih.gov/pubmed/29950861 http://dx.doi.org/10.2147/OTT.S155541

Ejemplares similares

Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2017)

Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma
por: Liang, Chaojie, et al.
Publicado: (2018)

The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018)

Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis
por: Yao, Yizhou, et al.
Publicado: (2018)

FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
por: Yu, Chun-Peng, et al.
Publicado: (2017)

Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018)

Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma
por: Yue, Chaosen, et al.
Publicado: (2019)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

Expression, association with clinicopathological features and prognostic potential of CEP55, p-Akt, FoxM1 and MMP-2 in astrocytoma
por: Nie, Saisai, et al.
Publicado: (2020)

Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells
por: Qiu, Yebei, et al.
Publicado: (2020)

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
por: Nandi, Deeptashree, et al.
Publicado: (2021)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation
por: Yue, Chaosen, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis
por: Zhang, Qian, et al.
Publicado: (2020)

Modulation of MnSOD and FoxM1 is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells [Retraction]
Publicado: (2022)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma
por: Yue, Chaosen, et al.
Publicado: (2019)

Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage
por: Hui, Marco K. C., et al.
Publicado: (2011)

PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2017)

FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Deregulation of FoxM1b leads to tumour metastasis
por: Park, Hyun Jung, et al.
Publicado: (2011)

Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma
por: Jiang, Hongyuan, et al.
Publicado: (2016)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
por: Lee, Yangkyu, et al.
Publicado: (2018)

miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis
por: Liang, Chaojie, et al.
Publicado: (2017)

FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter
por: Huang, Chao, et al.
Publicado: (2019)

FoxM1 is a promising candidate target in the treatment of breast cancer
por: Lu, Xiao-Feng, et al.
Publicado: (2017)

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
por: Jiao, Xiaodong, et al.
Publicado: (2018)

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2018)

Silencing of FoxM1 blocks growth, migration and invasion of papillary thyroid carcinoma cells
por: Wang, Xiaotao, et al.
Publicado: (2020)

Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance
por: Zhang, Jing, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Min, Zhao, et al.
Publicado: (2021)

Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma
por: Li, Guanqun, et al.
Publicado: (2022)

Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
por: Ogura, Satoshi, et al.
Publicado: (2018)

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy
por: He, Jian, et al.
Publicado: (2015)

Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
por: Xue, Yi-Jun, et al.
Publicado: (2012)

Novel functions of FoxM1: from molecular mechanisms to cancer therapy
por: Alvarez-Fernández, Mónica, et al.
Publicado: (2013)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vg095tck9jkfh4tqv7a8tsoqo0